LATEST ALERTS
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has begun the process of collecting data and evaluating the risk posed by hexahydrocannabinol (HHC) and other semi-synthetic cannabinoids that are now popping up in European markets.
At their first meeting, in Lisbon on 16th December, 140 experts from a network of member state authorities set out “to analyse, assess and discuss available information and how to fill knowledge gaps”. They discussed the scientific profile and pharmacology of HHC and examined how these semi-synthetic cannabinoids became so popular in the US under the 2018 Farm Bill.
